H.R. 4116 · 115th Congress
Transparent Drug Pricing Act of 2017
- Stage
- In committee
- Sponsor
- Lloyd Doggett
- Introduced
- 2017-10-25
- Latest action
- 2017-10-27 · Referred to the Subcommittee on Health.
Subjects
Congressional oversight
Health care costs and insurance
Wages and earnings
Government studies and investigations
Health
Inflation and prices
Medical research
Research administration and funding
Research and development
Small business
Intellectual property
Prescription drugs
Corporate finance and management
Marketing and advertising
Business records
Product development and innovation
Accounting and auditing